Terpenoid Therapeutics
Coralville, US · Iowa corporation
Founders & leadership
MD
Mark DrishNamed on SEC filing
JD
Jeffrey D. NeighborsNamed on SEC filing
DW
David WiemerNamed on SEC filing
CN
Curt NelsonNamed on SEC filing
RJ
Raymond J. HohlNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.3M disclosed across 2 rounds · 2012–2016
▶$535.9KraisedNov 2017 · 5 investors · PharmaceuticalsRule 506(b)
▶$535.9KraisedNov 2017 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Mark DrishDirector
- Jeffrey D. NeighborsExecutive Officer
- David WiemerExecutive Officer, Director
- Curt NelsonDirector
- Raymond J. HohlExecutive Officer, Director
- Offering amount
- $535.9K
- Amount sold
- $535.9K
- Minimum investment
- $50K
- First sale
- Mar 2016
- Incorporated
- Corporation, Iowa
- Federal exemptions
- 06b
▶$802.5KraisedNov 2017 · 10 investors · PharmaceuticalsRule 506(b)
▶$802.5KraisedNov 2017 · 10 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey D. NeighborsExecutive Officer
- David F WeimerDirector
- Curt NelsonDirector
- Mark J DrishDirector
- Steven CollinsExecutive Officer, Director
- Raymond J HohlExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $802.5K
- Minimum investment
- $25K
- First sale
- May 2012
- Incorporated
- Corporation, Iowa
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Terpenoid Therapeutics raised?
- Terpenoid Therapeutics has disclosed $1.3M raised across 2 rounds.
- Where is Terpenoid Therapeutics headquartered?
- Terpenoid Therapeutics is headquartered in Coralville, US.